BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17079288)

  • 1. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells.
    Badr G; Bédard N; Abdel-Hakeem MS; Trautmann L; Willems B; Villeneuve JP; Haddad EK; Sékaly RP; Bruneau J; Shoukry NH
    J Virol; 2008 Oct; 82(20):10017-31. PubMed ID: 18667516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.
    Park SH; Shin EC; Capone S; Caggiari L; De Re V; Nicosia A; Folgori A; Rehermann B
    Gastroenterology; 2012 Oct; 143(4):1048-60.e4. PubMed ID: 22705008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
    Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
    Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.
    Gruener NH; Lechner F; Jung MC; Diepolder H; Gerlach T; Lauer G; Walker B; Sullivan J; Phillips R; Pape GR; Klenerman P
    J Virol; 2001 Jun; 75(12):5550-8. PubMed ID: 11356962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
    Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
    J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically distinct virus-specific CD8 T cells defined by interleukin-7R{alpha} (CD127) and perforin expression.
    Cellerai C; Perreau M; Rozot V; Bellutti Enders F; Pantaleo G; Harari A
    J Virol; 2010 Apr; 84(8):3868-78. PubMed ID: 20130059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.
    Bowen DG; Shoukry NH; Grakoui A; Fuller MJ; Cawthon AG; Dong C; Hasselschwert DL; Brasky KM; Freeman GJ; Seth NP; Wucherpfennig KW; Houghton M; Walker CM
    J Virol; 2008 May; 82(10):5109-14. PubMed ID: 18337576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.
    Wölfl M; Rutebemberwa A; Mosbruger T; Mao Q; Li HM; Netski D; Ray SC; Pardoll D; Sidney J; Sette A; Allen T; Kuntzen T; Kavanagh DG; Kuball J; Greenberg PD; Cox AL
    J Immunol; 2008 Nov; 181(9):6435-46. PubMed ID: 18941234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.
    Billerbeck E; Kang YH; Walker L; Lockstone H; Grafmueller S; Fleming V; Flint J; Willberg CB; Bengsch B; Seigel B; Ramamurthy N; Zitzmann N; Barnes EJ; Thevanayagam J; Bhagwanani A; Leslie A; Oo YH; Kollnberger S; Bowness P; Drognitz O; Adams DH; Blum HE; Thimme R; Klenerman P
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3006-11. PubMed ID: 20133607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.
    Accapezzato D; Francavilla V; Paroli M; Casciaro M; Chircu LV; Cividini A; Abrignani S; Mondelli MU; Barnaba V
    J Clin Invest; 2004 Apr; 113(7):963-72. PubMed ID: 15057302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of peripheral and intratumoral KLRG1
    Zeng J; Zhang L; Ma S; Dai W; Xu M; Wei Y; Zhang Y; Cheng Y; Zhu G; Lu S; Li Q; Cao B
    Transl Oncol; 2024 May; 45():101968. PubMed ID: 38713923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells.
    Goyal NA; Coulis G; Duarte J; Farahat PK; Mannaa AH; Cauchii J; Irani T; Araujo N; Wang L; Wencel M; Li V; Zhang L; Greenberg SA; Mozaffar T; Villalta SA
    Neurology; 2022 Mar; 98(13):e1374-e1383. PubMed ID: 35131904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLRG1, Another Opportunity for a Breakthrough in MTCL.
    Varma G; Diefenbach CS
    Clin Cancer Res; 2024 Apr; ():. PubMed ID: 38568191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLRG1
    Renkema KR; Huggins MA; Borges da Silva H; Knutson TP; Henzler CM; Hamilton SE
    J Immunol; 2020 Aug; 205(4):1059-1069. PubMed ID: 32611727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired thymic output in patients with chronic hepatitis C virus infection.
    Hartling HJ; Gaardbo JC; Ronit A; Salem M; Laye M; Clausen MR; Skogstrand K; Gerstoft J; Ullum H; Nielsen SD
    Scand J Immunol; 2013 Oct; 78(4):378-86. PubMed ID: 23841696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological Monitoring in Hepatitis C Virus Controlled Human Infection Model.
    Shoukry NH; Cox AL; Walker CM
    Clin Infect Dis; 2023 Aug; 77(Suppl 3):S270-S275. PubMed ID: 37579206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'.
    Passos-Castilho AM; Udhesister STP; Fontaine G; Jeong D; Dickie M; Lund C; Russell R; Kronfli N
    Can Liver J; 2023 Feb; 6(1):56-69. PubMed ID: 36908576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide acyl chain saturation drives CD8
    Edwards-Hicks J; Apostolova P; Buescher JM; Maib H; Stanczak MA; Corrado M; Klein Geltink RI; Maccari ME; Villa M; Carrizo GE; Sanin DE; Baixauli F; Kelly B; Curtis JD; Haessler F; Patterson A; Field CS; Caputa G; Kyle RL; Soballa M; Cha M; Paul H; Martin J; Grzes KM; Flachsmann L; Mitterer M; Zhao L; Winkler F; Rafei-Shamsabadi DA; Meiss F; Bengsch B; Zeiser R; Puleston DJ; O'Sullivan D; Pearce EJ; Pearce EL
    Nat Immunol; 2023 Mar; 24(3):516-530. PubMed ID: 36732424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.